URGO Group

Wound Care & Consumer Healthcareurgo-group.fr

URGO Group is a privately-held French pharmaceutical and medical device company that manufactures wound care, consumer health, and complex pathology products under 20+ brands across more than 60 countries.

Company typePrivate
Founded1987
HeadquartersParis, France
Headcount1,001–5,000
GTM typeB2B and B2C
OfferingHardware or Manufacturing

URGO Group firmographics

Firmographics

Name: URGO Group
Legal name: URGO SAS
Website: https://urgo-group.fr
Company type: Private
Founded year: 1987
Operating status: Operating
Headcount range: 1,001–5,000 employees
Short description: URGO Group is a privately-held French pharmaceutical and medical device company that manufactures wound care, consumer health, and complex pathology products under 20+ brands across more than 60 countries.
Ownership category
akta.pro rank

Where URGO Group is headquartered

Location

Headquarters

HQ city: Paris
HQ country: France
HQ region: Europe

Offices5 records

Markets served

URGO Group business model

Business model

GTM type: B2B and B2C
Offering type: Hardware or Manufacturing
Cost components: Operations, Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

Pharmaceutical and Medical Products: URGO Group generates revenue through the sale of proprietary pharmaceutical products, medical devices, and health consumer products across wound care, consumer health, and complex pathology segments.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels2 records

URGO Group product offering

Product offering

Core offering

URGO Group is a French pharmaceutical and medical device company that manufactures and distributes healthcare products across three segments: wound care (advanced dressings and compression therapy), consumer health (OTC medicines, dietary supplements and personal hygiene products) and complex pathology (medical nutrition and treatments for specific pathological conditions). The company operates 12 industrial sites, manufactures approximately 80% of its products in France, and sells in more than 60 countries through 21 international subsidiaries and partnerships with pharmacy networks.

Product overview

URGO Group is a global pharmaceutical company organized around three core business segments: wound care (including advanced technologies like URGO K2), consumer health (spanning oral health, intimate care, and nutritional supplements), and complex pathology treatments. The company operates a multi-brand portfolio strategy, with the primary Urgo brand supported by acquired brands (Mercurochrome, Ricqlès) and specialized sub-brands. The portfolio emphasizes 'made in France' manufacturing, with approximately 80% of products produced domestically, and combines scientific expertise with cutting-edge medical technologies to serve healthcare professionals and patients across over 60 countries.

Differentiator

Problem solved

Functional benefit

Brands

Belloc: Marque de santé grand public
Intimy Care
Healico
Urgo K2
CicaManuka
Comptoirs et Compagnies
Herbesan
OM3
Intimy
Marie Rose
Eostra
Mercurochrome
Esprit Bio
Juvamine
Oligocéan
Humer
Alvityl
Superdiet
Urgo
Ricqlès
Juva Santé
URGO Healthcare
URGO Medical & Healthcare

Products and services

URGO Wound Care Dressings Advanced wound dressings and wound care products using URGO's proprietary lipidocolloid matrix technology and Manuka honey-based formulations for the management of acute and chronic wounds. Sold to hospitals, pharmacies and healthcare professionals.
URGO Compression Therapy (UrgoK2, UrgoK1) Multi-layer compression bandage systems for the treatment of venous leg ulcers, lymphedema and related vascular conditions. Targeted at healthcare professionals and institutions.
Mercurochrome Recognized French antiseptic and minor wound care consumer brand sold in pharmacies and parapharmacies for everyday first-aid needs.
Juvamine Range of dietary supplements (vitamins, minerals, beauty and slimming formulations) marketed to consumers through pharmacy and retail channels.
Ricqlès Traditional Ricqlès mint concentrate and related herbal remedy products sold to consumers for digestive wellness.
Humer Nasal hygiene and respiratory care products (saline sprays, decongestants) marketed to consumers for everyday respiratory wellness.
Alvityl Range of vitamin, tonic and fortifying products for children and adults, sold through pharmacy channels.
URGO Complex Pathology / Medical Nutrition Medical nutrition products and treatments targeting complex pathological conditions (such as rare dermatological conditions, scarring and post-surgical recovery), developed for healthcare professionals and patients.

Companies that use URGO Group

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

URGO Group technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

URGO Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

PitchercoreTechnology or Integration · 23 February 2026URGO Group partnered with Pitcher for commercial enablement across regulated industries. This partnership supports URGO's sales enablement initiatives, enhancing client engagement and data-driven content management. The partnership was announced alongside similar deals with Demant and Rabobank, representing continued adoption of Pitcher's sales enablement platform in healthcare and financial services.

Scale indicators12 records

Recent moves8 records

Expansion highlights6 records

URGO Group competitors and assessment

Company assessment

Direct peers

Mölnlycke Health Care: Swedish global leader in wound care and surgical solutions, with Mölnlycke foam dressings and Avance negative pressure wound therapy as direct analogues to URGO's wound care portfolio. Highly comparable in product category, B2B healthcare professional GTM, and clinical focus.
Coloplast: Danish medical device company specializing in wound care, ostomy, continence, and skin care. Operates a similar hospital-and-pharmacy distribution model with proprietary dressing technology, making it a strong peer for URGO's wound care and intimate care segments.
ConvaTec: UK-listed medical products company focused on advanced wound care, ostomy care, continence care, and infusion sets. Highly comparable in product categories (advanced dressings, ostomy), hospital distribution model, and European manufacturing footprint.
Paul Hartmann Group: German family-owned medical and hygiene products manufacturer with strong wound care and incontinence portfolios. Comparable business model as a privately-held, German-speaking European mid-cap focused on professional wound management and consumer hygiene.
Smith & Nephew: UK-listed global medical technology company with an Advanced Wound Management division offering comparable products (Allevyn, PICO negative pressure wound therapy). Direct overlap in advanced wound dressings and hospital channel GTM.

Broad incumbents

Beiersdorf: German consumer goods major owning Hansaplast/Elastoplast, the leading mass-market wound care brand in Europe. Overlaps with URGO's consumer wound care and OTC pharmacy channel strategy as a much larger incumbent with broader personal care portfolio.
B. Braun: German medical and pharmaceutical device company with hospital-focused wound care, infusion therapy, and surgical products. Comparable in B2B hospital sales model and European manufacturing footprint, though much broader portfolio than URGO.
3M Health Care: US-listed conglomerate's Health Care division includes advanced wound care (Tegaderm) and surgical solutions. Comparable in advanced wound dressing technology and hospital GTM, though part of a much larger diversified industrial portfolio.
Bayer Consumer Health: OTC and consumer health division of Bayer, with comparable pharmacy-distributed self-care brands (Bepanthen, Canesten) overlapping with URGO's consumer health portfolio. Much larger incumbent operating as a global pharma conglomerate.
Perrigo: US-listed consumer self-care company focused on OTC pharmaceuticals, personal care, and nutritional products. Comparable in OTC consumer health distribution through pharmacy channels, particularly relevant to URGO's Juva Santé consumer health division.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

URGO Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

URGO Group leadership team

Management profile

Number of profiles

Profiles2 records

URGO Group subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

URGO Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

URGO Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about URGO Group

What does URGO Group do?

Is URGO Group a public or private company?

URGO Group is a private company. It is classified as family owned and is currently operating.

When was URGO Group founded?

URGO Group was founded in 1987. It employs 1,001 to 5,000 people.

Where is URGO Group based?

URGO Group is headquartered in Paris, France, in the Europe region.

How does URGO Group make money?

One revenue line is on record: pharmaceutical and Medical Products.

Who are URGO Group's main competitors?

Direct peers on record are Mölnlycke Health Care, Coloplast, ConvaTec, Paul Hartmann Group and Smith & Nephew. Broad incumbents are Beiersdorf, B. Braun, 3M Health Care, Bayer Consumer Health and Perrigo.

Does URGO Group have an API?

No public API is recorded for URGO Group.